World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00356044
Date of registration: 24/07/2006
Prospective Registration: No
Primary sponsor: Hospital Juan Canalejo
Public title: Arterial Access for Coronary Intervention in Myocardial Infarction
Scientific title: Femoral Versus Radial Access for Coronary Intervention in the Acute Phase of ST-Elevation Myocardial Infarction
Date of first enrolment: May 2004
Target sample size: 439
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00356044
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 4
Countries of recruitment
Spain
Contacts
Name:     Andrés Iñiguez-Romo, MD
Address: 
Telephone:
Email:
Affiliation:  Hospital do Meixoeiro
Name:     Antonio Amaro-Cendón, MD
Address: 
Telephone:
Email:
Affiliation:  Complejo Hospitalario Universitario de Santiago
Name:     Nicolás Vázquez-González, MD
Address: 
Telephone:
Email:
Affiliation:  Hospital Juan Canalejo
Name:     Jose M Vazquez-Rodriguez, MD
Address: 
Telephone:
Email:
Affiliation:  Hospital Juan Canalejo
Name:     Ramón Calviño-Santos, MD
Address: 
Telephone:
Email:
Affiliation:  Hospital Juan Canalejo
Name:     Ramiro Trillo, Nouche
Address: 
Telephone:
Email:
Affiliation:  Complejo Hospitalario Universitario de Santiago
Name:     Jose A Baz, Alonso
Address: 
Telephone:
Email:
Affiliation:  Hospital do meixoeiro
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients with ST elevation acute myocardial infarction referred for
primary,facilitated or of rescue coronary angioplasty in the first 12 hours since the
start of the symptoms.

Exclusion Criteria:

- Patients in cardiogenic shock were excluded following operator criteria.

- Previous coronary surgery with mammary artery graft

- Coronary artery intervention in the previous month

- Absolute or relative contraindication for access via the radial artery route:Radial
pulse absent or weak, abnormal Allen test,anatomy known to impede the use of the
radial route or hemodialysis or advanced chronic renal insufficiency (creatinine >3
mg/dl).

- Patients with absolute or relative contraindication for the use of the femoral route.

- Absence of informed consent from the patient



Age minimum: 18 Years
Age maximum: 80 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Angioplasty, Transluminal, Percutaneous Coronary
Myocardial Infarction
Myocardial Reperfusion
Intervention(s)
Procedure: Coronary angioplasty
Primary Outcome(s)
New ST elevation acute myocardial infarction at 30 days [Time Frame: within the first 30 days (plus or minus 5 days) after the index myocardial infarction]
All cause mortality at 30 days [Time Frame: within the first 30 days (plus or minus 5 days) after the index myocardial infarction]
Coronary revascularization as a result of recurrent ischemia at 30 days [Time Frame: within the first 30 days (plus or minus 5 days) after the index myocardial infarction]
Major vascular complications at 30 days. [Time Frame: within the first 30 days (plus or minus 5 days) after the index myocardial infarction]
Secondary Outcome(s)
Embolic stroke at 30 days [Time Frame: within the first 30 days (plus or minus 5 days) after the index myocardial infarction]
Cardiovascular mortality at 30 days [Time Frame: within the first 30 days (plus or minus 5 days) after the index myocardial infarction]
Coronary revascularization at 30 days [Time Frame: within the first 30 days (plus or minus 5 days) after the index myocardial infarction]
Procedural time
Estimation of costs
Hospital stay
Secondary ID(s)
CEICG 2004/063
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history